UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000014740
Receipt No. R000017132
Scientific Title Phase 2 study of efficacy and safety of concurrent WBRT with erlotinib and followed by erlotinib plus bevacizumab in patients with newly diagnostic brain metastatisis stage IV non-sq NSCLC
Date of disclosure of the study information 2014/09/01
Last modified on 2015/02/04 19:25:33

No. Disposal Last modified on Item of update
1 Insert 2014/08/01 17:55:45
2 Update 2015/02/04 19:25:33 Interventions/Control_1
Interventions/Control_1
Key exclusion criteria
Key exclusion criteria


Contact us.